- 专利标题： Use of cannabinoids in the treatment of inflammatory skin diseases
-
申请号： US15763186申请日： 2016-09-29
-
公开(公告)号： US11413266B2公开(公告)日： 2022-08-16
- 发明人: Tamás Biró , Colin Stott , Vincenzo Di Marzo
- 申请人： GW Pharma Limited
- 申请人地址： GB Cambridge
- 专利权人： GW Pharma Limited
- 当前专利权人： GW Pharma Limited
- 当前专利权人地址： GB Cambridge
- 代理机构： Wolf, Greenfield & Sacks, P.C.
- 优先权： GB1517215 20150929
- 国际申请： PCT/GB2016/053027 WO 20160929
- 国际公布： WO2017/055846 WO 20170406
- 主分类号： A61K31/352
- IPC分类号： A61K31/352 ; A61K31/047 ; A61K45/06 ; A61K31/191 ; A61K9/00
摘要：
The present invention relates to the use of one or more cannabinoids in the treatment of an inflammatory skin disease. Preferably the one or more cannabinoids are taken from the group consisting of: cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), cannabigervarin (CBGV) and tetrahydrocannabivarin (THCV). The inflammatory skin disease may be caused by one or more of the following: microbial infection-induced dermatitis; solar dermatitis; atopic dermatitis; and allergic contact dermatitis.
公开/授权文献
信息查询
